HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical outcomes for pediatric patients receiving radiotherapy for solid tumor central nervous system metastases.

Abstract
Central nervous system (CNS) metastases are rare, but devastating complications of pediatric solid tumors. Radiotherapy alone or postresection serves as an important treatment; however, data on the use of whole-brain radiotherapy (WBRT) versus focal radiotherapy, including stereotactic radiosurgery or stereotactic radiotherapy, for these indications are limited. We report a single institution experience of 26 pediatric patients treated with radiotherapy for solid tumor CNS metastases without leptomeningeal disease. Focal radiotherapy (n = 10) was well tolerated and survival outcomes did not differ between patients treated with WBRT (n = 16) versus focal radiation, suggesting that focal radiotherapy may be considered for patients with limited CNS metastases.
AuthorsThomas P Howard, Patrick J Boyle, Karen J Marcus, Daphne A Haas-Kogan, Kevin X Liu
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 68 Issue 12 Pg. e29331 (12 2021) ISSN: 1545-5017 [Electronic] United States
PMID34569132 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2021 Wiley Periodicals LLC.
Topics
  • Brain Neoplasms (pathology)
  • Central Nervous System (pathology)
  • Child
  • Cranial Irradiation (adverse effects)
  • Humans
  • Meningeal Neoplasms
  • Neoplasms, Second Primary (etiology)
  • Radiosurgery (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: